source
- FDA advisory panel recommends adding peptides BPC-157 and KPV to bulk compounding listAn FDA advisory committee voted 8-6, with one abstention, to recommend that two experimental peptides – BPC-157 for ulcerative colitis and KPV for wound and inflammatory conditions – be placed on t…
- FDA advisory panel adds six peptides to compounding bulk drug list, rejects oneThe FDA’s advisory committee concluded a two-day meeting on Friday, reviewing seven peptide drug substances for inclusion on the agency’s bulk-drug compounding list. Committee members voted to add…